Celldex Therapeutics Ratios (2010-2025) | CLDX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)													-738.46%	35.35%	66.34%	-37.36%	-211.94%	-111.51%		-914.88%
EBT Margin (Quarter)	-2,414.31%	-384.28%	-13,515.69%	-6,032.34%	-13,247.13%	-22,088.34%	-6,580.84%	-1,642.10%	-3,036.30%	-11,381.34%	-2,522.08%	-1,048.32%	-21,030.77%	-1,434.83%	-1,319.99%	-4,007.83%	-7,740.43%	-7,753.42%		-67,204.13%
EBIT Margin (Quarter)	-2,429.05%	-386.21%	-13,610.46%	10,792.81%	-13,366.09%	-22,328.83%	-6,804.91%	-1,728.77%	-3,357.91%	-12,389.93%	-2,718.46%	-1,152.92%	-26,030.77%	-1,854.16%	-1,633.53%	-4,768.26%	-9,027.19%	-8,747.53%		-72,027.27%
EBITDA Margin (Quarter)	-2,414.60%	-384.14%	-13,396.08%	-6,228.14%	-14,271.26%	-22,412.88%	-6,505.90%	-1,557.04%	-2,947.05%	-11,400.37%	-2,517.93%	-1,019.92%	-21,712.82%	-1,453.40%	-1,210.06%	-4,175.83%	-7,703.88%	-7,784.79%		-67,319.01%
Operating Margin (Quarter)	-2,429.05%	-386.21%	-13,610.46%	10,792.81%	-13,366.09%	-22,328.83%	-6,804.91%	-1,728.77%	-3,357.91%	-12,389.93%	-2,718.46%	-1,152.92%	-26,030.77%	-1,854.16%	-1,633.53%	-4,768.26%	-9,027.19%	-8,747.53%		-72,027.27%
Net Margin (Quarter)	-2,414.31%	-384.28%	-13,367.32%	-6,032.34%	-13,247.13%	-22,088.34%	-6,580.84%	-1,642.10%	-3,036.30%	-11,381.34%	-2,522.08%	-1,048.32%	-21,030.77%	-1,434.83%	-1,319.99%	-4,005.36%	-7,741.01%	-7,753.42%		-67,204.13%
FCF Margin (Quarter)	-2,722.77%	-346.93%	-10,821.57%	-4,454.19%	-14,430.46%	-14,059.51%	-8,731.45%	-1,363.73%	-3,014.89%	-10,300.75%	-1,262.36%	-803.66%	-26,270.51%	-1,184.99%	-1,751.24%	-2,828.26%	-7,861.44%	-6,127.81%		-53,901.65%
Efficiency
Assets Average (Quarter)	227.45M	211.81M	332.38M	452.43M	434.35M	413.50M	386.09M	360.98M	338.63M	311.92M	289.78M	372.94M	667.24M	857.22M	834.38M	807.76M	765.91M	715.94M	670.42M	615.71M
Equity Average (Quarter)	201.76M	188.22M	309.50M	428.09M	408.79M	381.60M	355.25M	335.81M	314.47M	290.14M	262.13M	337.94M	633.89M	826.14M	799.78M	766.46M	724.99M	679.19M	626.88M	562.76M
Invested Capital (Quarter)	194.17M	182.28M	436.71M	419.48M	398.10M	365.09M	345.42M	326.20M	302.74M	277.54M	246.72M	429.17M	838.61M	813.66M	785.90M	747.00M	702.98M	655.41M	598.36M	527.16M
Asset Utilization Ratio (Quarter)	0.02	0.04	0.02	0.01	0.01	0.00	0.00	0.01	0.01	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.89	0.89	0.95	0.94	0.94	0.91	0.94	0.92	0.93	0.93	0.88	0.92	0.97	0.96	0.95	0.94	0.95	0.95	0.92	0.90
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-176.08M	-164.04M	-423.09M	-408.25M	-380.47M	-356.82M	-323.47M	-304.95M	-278.39M	-252.70M	-235.35M	-423.60M	-823.85M	-802.32M	-756.00M	-725.28M	-673.29M	-630.34M	-583.22M	-518.57M
Return Ratios
Return on Sales (Quarter)	-24.14%	-3.84%	-133.67%	-60.40%	-132.47%	-220.88%	-65.81%	-16.42%	-30.36%	-113.81%	-25.22%	-10.48%	-210.31%	-14.35%	-13.20%	-40.08%	-77.40%	-77.53%	-86.36%	-672.04%
Return on Capital Employed (Quarter)	-0.32%	-0.35%	-0.24%	-0.03%	-0.05%	-0.12%	-0.14%	-0.34%	-0.38%	-0.41%	-0.51%	-0.45%	-0.25%	-0.21%	-0.23%	-0.25%	-0.30%	-0.34%	-0.41%	-0.51%
Return on Invested Capital (Quarter)			-0.25%	-0.04%
Return on Assets (Quarter)	-0.29%	-0.32%	-0.22%	-0.16%	-0.18%	-0.24%	-0.27%	-0.31%	-0.35%	-0.36%	-0.43%	-0.38%	-0.22%	-0.18%	-0.18%	-0.20%	-0.23%	-0.28%	-0.33%	-0.42%
Return on Equity (Quarter)	-0.32%	-0.36%	-0.24%	-0.16%	-0.19%	-0.26%	-0.30%	-0.33%	-0.38%	-0.39%	-0.48%	-0.42%	-0.23%	-0.18%	-0.19%	-0.21%	-0.25%	-0.29%	-0.36%	-0.46%

Research Tools

Celldex Therapeutics Ratios (2010-2025) | CLDX

Create an account

Sign In

Reset Password